Sangamo Therapeutics, Inc.
| Security | SGMO / Sangamo Therapeutics, Inc. |
| Insider | Sandy Macrae |
This page shows the track record and history of Macrae Sandy
insider trades in Sangamo Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Sandy Macrae in SGMO / Sangamo Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Sandy Macrae in SGMO / Sangamo Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-26 | 2025-08-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.5863 | -7,488 | -4 | 2,183,972 | ||||
| 2025-07-24 | 2025-07-22 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.4798 | -126,950 | -61 | 2,191,460 | ||||
| 2025-05-28 | 2025-05-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.4733 | -7,488 | -4 | 2,318,410 | ||||
| 2025-04-24 | 2025-04-22 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.7763 | -126,950 | -99 | 2,325,898 | ||||
| 2025-02-26 | 2025-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 375,000 | 2,452,848 | ||||||
| 2025-02-26 | 2025-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.9561 | -10,663 | -10 | 2,077,848 | ||||
| 2025-02-26 | 2025-02-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 1.0000 | -7,488 | -7 | 2,088,511 | ||||
| 2025-01-24 | 2025-01-22 | 4 | Macrae Sandy | SGMO | Common Stock | D | 1.1500 | -412,584 | -474 | 2,095,999 | ||||
| 2024-11-26 | 2024-11-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 1.9400 | -10,642 | -21 | 2,508,583 | ||||
| 2024-11-26 | 2024-11-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 1.8800 | -7,473 | -14 | 2,519,225 | ||||
| 2024-08-27 | 2024-08-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.8600 | -7,492 | -6 | 2,526,698 | ||||
| 2024-08-27 | 2024-08-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.8600 | -5,261 | -5 | 2,534,190 | ||||
| 2024-05-29 | 2024-05-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.6000 | -7,492 | -4 | 2,539,451 | ||||
| 2024-05-29 | 2024-05-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.6000 | -5,261 | -3 | 2,546,943 | ||||
| 2024-02-27 | 2024-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 1.1300 | -24,157 | -27 | 2,552,204 | ||||
| 2024-02-27 | 2024-02-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 1.1300 | -16,115 | -18 | 2,576,361 | ||||
| 2024-01-24 | 2024-01-22 | 4 | Macrae Sandy | SGMO | Common Stock | D | 2,000,000 | 2,592,476 | ||||||
| 2023-11-28 | 2023-11-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.3821 | -10,411 | -4 | 592,476 | ||||
| 2023-08-29 | 2023-08-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 0.7700 | -10,411 | -8 | 602,887 | ||||
| 2023-05-30 | 2023-05-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 1.3300 | -10,411 | -14 | 613,298 | ||||
| 2023-03-06 | 2023-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 2.6600 | -54,767 | -146 | 623,709 | ||||
| 2023-03-06 | 2023-02-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 157,300 | 678,476 | ||||||
| 2022-03-01 | 2022-02-25 | 4 | Macrae Sandy | SGMO | Stock Option (Right to Buy) | D | 5.90 | 604,800 | 604,800 | |||||
| 2022-03-01 | 2022-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 224,000 | 521,176 | ||||||
| 2022-03-01 | 2022-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 5.9000 | -49,890 | -294 | 297,176 | ||||
| 2021-03-01 | 2021-02-25 | 4 | Macrae Sandy | SGMO | Stock Option (Right to Buy) | D | 11.19 | 276,750 | 276,750 | |||||
| 2021-03-01 | 2021-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 138,375 | 347,066 | ||||||
| 2021-03-01 | 2021-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 11.1900 | -35,311 | -395 | 208,691 | ||||
| 2021-01-26 | 2021-01-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 14.9500 | -3,977 | -59 | 244,002 | ||||
| 2020-02-26 | 2020-02-25 | 4 | Macrae Sandy | SGMO | Stock Option (Right-to-Buy) | D | 6.80 | 337,500 | 337,500 | |||||
| 2020-02-26 | 2020-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 168,750 | 247,979 | ||||||
| 2020-02-26 | 2020-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 6.8000 | -7,264 | -49 | 79,229 | ||||
| 2020-01-28 | 2020-01-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 7.5000 | -4,283 | -32 | 86,493 | ||||
| 2019-02-27 | 2019-02-25 | 4 | Macrae Sandy | SGMO | Stock Option (Right-to-Buy) | D | 9.03 | 379,500 | 379,500 | |||||
| 2019-02-27 | 2019-02-25 | 4 | Macrae Sandy | SGMO | Common Stock | D | 63,250 | 90,776 | ||||||
| 2019-01-28 | 2018-01-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 11.1000 | -3,974 | -44 | 27,526 | ||||
| 2018-01-31 | 2018-01-24 | 4 | Macrae Sandy | SGMO | Stock Option (Right to Buy) | D | 20.05 | 189,000 | 189,000 | |||||
| 2018-01-31 | 2018-01-24 | 4 | Macrae Sandy | SGMO | Common Stock | D | 31,500 | 31,500 | ||||||
| 2017-01-30 | 2017-01-26 | 4 | Macrae Sandy | SGMO | Employee Stock Option (Right to Buy) | D | 3.50 | 360,000 | 360,000 | |||||
| 2016-06-06 | 2016-06-03 | 4 | Macrae Sandy | SGMO | Employee Stock Option (Right to Buy) | D | 7.07 | 700,000 | 700,000 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
